Esomeprazole and Radiation Induced Esophagitis

Thoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer (NSCLC).

Trial Details

NCT ID
NCT06120803
Phase
PHASE2
Sponsor
Rush University Medical Center
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Esomeprazole 40 mg
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005

Key Eligibility Criteria

  • Patient is ≥ 18 years of age.
  • Patient or patient's legal representative is willing and able to provide written informed consent and HIPAA authorization prior to performance of a…
  • Patient is willing and able to comply with scheduled visits and treatment schedules.
  • Patient has histopathologically confirmed diagnosis of NSCLC clinical stage III (as per the 8th edition of American Joint Committee on Cancer Stagi…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →